The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort — Stella

Home/Hepatitis B/

View on ClinicalTrials.gov

Recruiting

Back to Hepatitis B trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Taiwan

Family Medicine, NTUH, Taipei

Key details

Sponsor

National Taiwan University Hospital

Collaborators

Academia Sinica, Taiwan, Ministry of Science and Technology, Taiwan

Enrollment target

~240 participants

Started

August 2021

Primary completion

December 2027

Age range

20 Years – 36 Years

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.